Selected morphologic features influencing the prognosis of conventional	 renal cell carcinomas co-expressing P53 and MDM2

Maria Hejnold; Grzegorz Dyduch; Magdalena Białas; Sergiusz Demczuk; Janusz Ryś; Tomasz Szopiński; Piotr Chłosta; Krzysztof Okoń

doi:10.5114/pjp.2014.42666

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2014
vol. 65

Send email

Copy url:

abstract:

Selected morphologic features influencing the prognosis of conventional renal cell carcinomas co-expressing P53 and MDM2

Maria Hejnold

,

Grzegorz Dyduch

,

Magdalena Białas

,

Sergiusz Demczuk

,

Janusz Ryś

,

Tomasz Szopiński

,

Piotr Chłosta

,

Krzysztof Okoń

Pol J Pathol 2014; 65 (1): 29-33

DOI: https://doi.org/10.5114/pjp.2014.42666

Online publish date: 2014/05/13

View full text Get citation

PlumX metrics:

Renal cell carcinoma is the most deadly of common urologic malignancies. The classical prognostic factors, including tumor type, grade and stage, as well as performance status of the patient, offer important information, but there is a need for new biomarkers which could improve the quality of prognostication. It has been proposed that tumors co-expressing P53 and MDM2 could represent a specific, more aggressive subgroup. The aim of the study was to explore this hypothesis using tissue microarrays, using two different anti-P53 antibodies. The material analyzed consisted of 470 cases of renal clear cell carcinoma. Reaction for P53 was positive in 15.1 or 13.2% of cases, depending on the antibody used. Reaction for MDM2 was positive in 37.9% of cases; 6.5 or 5.3% of cases coexpressed P53 and MDM2. Both P53-positive and double P53/MDM2-positive cases were higher grade and more likely to contain a sarcomatoid component, but their stage was similar to negative cases. PAb1081 P53-positive MDM2-positive cases were larger than the rest of the tumors (7.6 cm vs. 6.1 cm, p < 0.001). Our data support the hypothesis of prognostic significance of P53, and double P53/MDM2 positivity, yet further studies are needed to clarify the issue.

keywords:

Selected morphologic features influencing the prognosis of conventional renal cell carcinomas co-expressing P53 and MDM2

Maria Hejnold , Grzegorz Dyduch , Magdalena Białas , Sergiusz Demczuk , Janusz Ryś , Tomasz Szopiński , Piotr Chłosta , Krzysztof Okoń

renal cell carcinoma, prognostic factors, P53, MDM2

Maria Hejnold

,

Grzegorz Dyduch

,

Magdalena Białas

,

Sergiusz Demczuk

,

Janusz Ryś

,

Tomasz Szopiński

,

Piotr Chłosta

,

Krzysztof Okoń